Genetic heterogeneity and tissue-specific patterns of tumors with multiple PIK3CA mutations.
Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Sivakumar, Smruthy S; Jin, Dexter X DX; Rathod, Ruchita R; Ross, Jeffrey J; Cantley, Lewis C LC; Scaltriti, Maurizio M; Chen, Jessica W JW; Hutchinson, Katherine E KE; Wilson, Timothy R TR; Sokol, Ethan S ES; Vasan, Neil N
Abemaciclib plus fulvestrant for the treatment of hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer with cystic brain metastases: A case report and literature review.
Analytical Performance of Next-Generation Sequencing and RT-PCR on Formalin-Fixed Paraffin-Embedded Tumor Tissues for PIK3CA Testing in HR+/HER2- Breast Cancer.
Cells
Venetis, Konstantinos K; Pepe, Francesco F; Munzone, Elisabetta E; Sajjadi, Elham E; Russo, Gianluca G; Pisapia, Pasquale P; Ivanova, Mariia M; Bonizzi, Giuseppina G; Vacirca, Davide D; Rappa, Alessandra A; Ranghiero, Alberto A; Taormina, Sergio Vincenzo SV; Viale, Giuseppe G; Troncone, Giancarlo G; Barberis, Massimo M; Guerini-Rocco, Elena E; Malapelle, Umberto U; Fusco, Nicola N
PIK3CA Mutation is Associated with Poor Response to HER2-Targeted Therapy in Breast Cancer Patients.
Cancer Research And Treatment
Kim, Ju Won JW; Lim, Ah Reum AR; You, Ji Young JY; Lee, Jung Hyun JH; Song, Sung Eun SE; Lee, Nam Kwon NK; Jung, Seung Pil SP; Cho, Kyu Ran KR; Kim, Cheol Yong CY; Park, Kyong Hwa KH
Anthracycline-Free Neoadjuvant Treatment in Patients with HER2-Positive Breast Cancer: Real-Life Use of Pertuzumab, Trastuzumab and Taxanes Association with an Exploratory Analysis of PIK3CA Mutational Status.
Cancers
Irelli, Azzurra A; Parisi, Alessandro A; D'Orazio, Carla C; Sidoni, Tina T; Rotondaro, Silvia S; Patruno, Leonardo L; Pavese, Francesco F; Bafile, Alberto A; Resta, Valter V; Pizzorno, Laura L; Ciuffetelli, Virginia V; Dal Mas, Antonella A; Calvisi, Giuseppe G; Di Sibio, Alessandra A; Marzullo, Anna A; Zelli, Veronica V; Compagnoni, Chiara C; Tessitore, Alessandra A; Alesse, Edoardo E; Ficorella, Corrado C; Cortellini, Alessio A; Cannita, Katia K
Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive, HER2-negative breast cancer (FAKTION): overall survival, updated progression-free survival, and expanded biomarker analysis from a randomised, phase 2 trial.
The Lancet. Oncology
Howell, Sacha J SJ; Casbard, Angela A; Carucci, Margherita M; Ingarfield, Kate K; Butler, Rachel R; Morgan, Sian S; Meissner, Magdalena M; Bale, Catherine C; Bezecny, Pavel P; Moon, Sarah S; Twelves, Chris C; Venkitaraman, Ramachandran R; Waters, Simon S; de Bruin, Elza C EC; Schiavon, Gaia G; Foxley, Andrew A; Jones, Robert H RH
Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncology study (NRG-GY008).
Gynecologic Oncology Reports
Santin, Alessandro D AD; Filiaci, Virginia V; Bellone, Stefania S; Ratner, Elena S ES; Mathews, Cara A CA; Cantuaria, Guilherme G; Gunderson, Camille C CC; Rutledge, Teresa T; Buttin, Barbara M BM; Lankes, Heather A HA; Frumovitz, Michael M; Khleif, Samir N SN; Huh, Warner K WK; Birrer, Michael J MJ
Phase II Study of Taselisib (GDC-0032) in Combination with Fulvestrant in Patients with HER2-Negative, Hormone Receptor-Positive Advanced Breast Cancer.
Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Dickler, Maura N MN; Saura, Cristina C; Richards, Donald A DA; Krop, Ian E IE; Cervantes, Andrés A; Bedard, Philippe L PL; Patel, Manish R MR; Pusztai, Lajos L; Oliveira, Mafalda M; Cardenas, Alison K AK; Cui, Na N; Wilson, Timothy R TR; Stout, Thomas J TJ; Wei, Michael C MC; Hsu, Jerry Y JY; Baselga, José J
PIK3CA mutation, reduced AKT serine 473 phosphorylation, and increased ERα serine 167 phosphorylation are positive prognostic indicators in postmenopausal estrogen receptor-positive early breast cancer.
Oncotarget
Ishida, Naoko N; Baba, Motoi M; Hatanaka, Yutaka Y; Hagio, Kanako K; Okada, Hiromi H; Hatanaka, Kanako C KC; Togashi, Kenichi K; Matsuno, Yoshihiro Y; Yamashita, Hiroko H
Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma.
Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Caumanns, Joseph J JJ; Berns, Katrien K; Wisman, G Bea A GBA; Fehrmann, Rudolf S N RSN; Tomar, Tushar T; Klip, Harry H; Meersma, Gert J GJ; Hijmans, E Marielle EM; Gennissen, Annemiek M C AMC; Duiker, Evelien W EW; Weening, Desiree D; Itamochi, Hiroaki H; Kluin, Roelof J C RJC; Reyners, Anna K L AKL; Birrer, Michael J MJ; Salvesen, Helga B HB; Vergote, Ignace I; van Nieuwenhuysen, Els E; Brenton, James J; Braicu, E Ioana EI; Kupryjanczyk, Jolanta J; Spiewankiewicz, Beata B; Mittempergher, Lorenza L; Bernards, René R; van der Zee, Ate G J AGJ; de Jong, Steven S
PIK3CA mutations are associated with increased tumor aggressiveness and Akt activation in gastric cancer.
Oncotarget
Kim, Ji-Won JW; Lee, Hye Seung HS; Nam, Kyung Han KH; Ahn, Soyeon S; Kim, Jin Won JW; Ahn, Sang-Hoon SH; Park, Do Joong DJ; Kim, Hyung-Ho HH; Lee, Keun-Wook KW
Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
The Lancet. Oncology
Kim, Sung-Bae SB; Dent, Rebecca R; Im, Seock-Ah SA; Espié, Marc M; Blau, Sibel S; Tan, Antoinette R AR; Isakoff, Steven J SJ; Oliveira, Mafalda M; Saura, Cristina C; Wongchenko, Matthew J MJ; Kapp, Amy V AV; Chan, Wai Y WY; Singel, Stina M SM; Maslyar, Daniel J DJ; Baselga, José J; ,
Tumor burden monitoring using cell-free tumor DNA could be limited by tumor heterogeneity in advanced breast cancer and should be evaluated together with radiographic imaging.
Bmc Cancer
García-Saenz, José Angel JA; Ayllón, Patricia P; Laig, Marion M; Acosta-Eyzaguirre, Daniel D; García-Esquinas, Marta M; Montes, Myriam M; Sanz, Julián J; Barquín, Miguel M; Moreno, Fernando F; Garcia-Barberan, Vanesa V; Díaz-Rubio, Eduardo E; Caldes, Trinidad T; Romero, Atocha A